PUBLISHER: Allied Market Research | PRODUCT CODE: 1179764
PUBLISHER: Allied Market Research | PRODUCT CODE: 1179764
The global sterility indicators market was valued at $879.3 million in 2021, and is projected to reach $2,599.3 million by 2031, registering a CAGR of 11.5% from 2022 to 2031. Sterility indicators is a medical device, which is used for testing presence of microorganisms. It confirms the products are free from the presence of viable micro-organism. It is an important device used in sterilization procedure of medical device and preparation of drugs. Sterility indicators are the indicators that are used to check the quality of sterilization and monitoring of the sterilization process. It may be also required to check whether microbial growth occurs or not in terms of sterilization quality. Sterilization indicators are instruments that support load monitoring, regular monitoring, and certification of steam sterilization processes. This instrument can demonstrate whether the circumstances in steam autoclaves are enough to achieve a particular stage of microbial inactivation. It is regarded as a crucial tool for testing the sterilization quality and preventing microbiological development in pharmaceutical preparations and medical devices.
The sterility indicators market is driven by increase in R&D activities by pharmaceutical industry, high prevalence of chronic diseases such as cancer, diabetes, arthritis, and cancer, and rising demand for medicines and medical devices. Sterility indicators are used in research centers and pharmaceutical companies to check sterility of the medicine and medical device for effective results. Thus, rise in the number of chronic diseases cause increase in demand for medicines and medical device. Therefore, this factor drives the demand for sterility indicators in pharmaceutical company and drives the growth of the market. For instance, according to World Health Organization (WHO), in 2020, approximately 2.26 million new breast cancer cases were diagnosed globally. Moreover, according to International Diabetes Federation (IDF), in 2021, approximately 537 million adults in the age group of 20-79 suffered from diabetes over the globe. The total number of people suffering from diabetes is projected to rise to 643 million by 2030 and 783 million by 2045.
In addition, rise in hospital acquired infection fuels the demand for sterility indicators, which further is anticipated to boost the growth of the sterility indicators market. Growing efforts to reduce hospital acquired infections (HAIs) or nosocomial infections is one of the high impacting factors for the market growth. The concept of hospital sterile processing unit is being adopted by developing countries, such as India, China, and Middle East countries. Therefore, rise in the number of sterilization process in hospital surge the growth of the sterility indicators market. Moreover, rise in use of E-beam sterilization and increase in awareness of environmental & personal hygiene due to COVID-19 fuel the growth of the market.
In addition, rise in the number of key players who manufacture sterility indicators, increase in the product launch and product approval for sterility indicators, and rise in expenditure by government to develop healthcare infrastructure are anticipated to fuel the growth of the sterility indicators market. For instance, according to the Centers for Medicare & Medicaid Services, the U.S. healthcare spending grew by 9.7% from 2020 to 2019, reaching $4.1 trillion ($12,530 per person). Similarly, as per the Office for National Statistics, total healthcare expenditure in UK accounted for 12.8% of the gross domestic product (GDP) in 2020, as compared to 10.2% in 2019. Furthermore, it has been estimated that approximately 30% of the healthcare expenditure is used in upgrading the healthcare infrastructure, especially medical equipment and medicine used at public health centers, such as hospitals. On the other hand, sterility indicator equipment flaws like the inability to identify operational issues like overloading the sterilizer, challenging package configuration in the load, improper sterilization equipment, noncompliance with sterilization standards, high device costs, and chemical exposure hamper the growth of the sterility indicators market.
The sterility indicators market is segmented on the basis of type, sterilization process, end user, and region. By type, the market is divided into chemical indicators and biological indicators. The biological indicators is further bifurcated into self-contained vials, spore strips, and others. On the basis sterilization process, the market is segmented into steam, ethylene oxide, dry heat, and others. Others includes hydrogen peroxide and formaldehyde. On the basis of end user, the market is segmented into hospitals, pharmaceutical companies and medical device companies, and clinical laboratories/research centers. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global sterility indicators market include, 3M Company, Anderson Products, Inc., Fortive Corporation, Cardinal, Crosstex International Inc., Getinge AB, gke-GmbH, Hu-Friedy Mfg. Co., LLC, Matachana Group, Mesa Labs, Inc., MMM Group, Nelson Laboratories, LLC, NOXILIZER INC, Propper Manufacturing Co., Inc., and STERIS plc.
Key Benefits For Stakeholders
By Type
By Sterilization Process
By End User
By Region